Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Performance and Safety of STYLAGE® HydroMax

NCT: NCT07153237 · ACTIVE_NOT_RECRUITING

NCT IDNCT07153237
StatusACTIVE_NOT_RECRUITING
Start Date2025-09-09
Completion2026-11-09
SponsorLaboratoires Vivacy (INDUSTRY)
First posted
Last updated

Brief Summary

FHAME is a post-market clinical investigation designed to strengthen the clinical evidence supporting the effectiveness of STYLAGE® HydroMax in the treatment of superficial wrinkles, primarily on the cheeks.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑